Your institution may have access to this item. Find your institution then sign in to continue.
Title
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.
Authors
Jendle, J.; Nauck, M. A.; Matthews, D. R.; Frid, A.; Hermansen, K.; Düring, M.; Zdravkovic, M.; Strauss, B. J.; Garber, A. J.